Erythropoietin response to anaemia in type 2 diabetic nephropathy with varying degrees of renal dysfunction

Diabetes and Metabolic Syndrome: Clinical Research and Reviews

Volumn 2, Issue 4, 2008, Pages 266-272

  Beg, M ^a   Khan, A R ^a   Katyal, P ^a   Siddiqui, M A ^a   Ahmad, J ^a  

^a ALIGARH MUSLIM UNIVERSITY   (India)

Author keywords

Diabetic nephropathy; Erythropoietin; Type 2 Diabetes

Indexed keywords

ALBUMIN; ANTIHYPERTENSIVE AGENT; ERYTHROPOIETIN; HEMOGLOBIN;

ADULT; ANEMIA; ARTICLE; BODY MASS; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG RESPONSE; ERYTHROCYTE COUNT; FEMALE; GLOMERULUS FILTRATION RATE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN TISSUE; HYPERTENSION; KIDNEY BIOPSY; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROTEINURIA; URINARY EXCRETION;

EID: 55549129588     PISSN: 18714021     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dsx.2008.04.009     Document Type: Article

References (36)

1. Hsu C.Y., Bates D.W., Kuperman G.J., and Curhan G.C. Relationship between hematocrit and renal function in men and women. Kidney Int 59 (2001) 725-731
2. Astor B.C., Muntner P., Levin A., Eustace J.A., and Coresh J. Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med 162 (2002) 1401-1408
3. Thomas M.C., MacIsaac R.J., Tsalamandris C., Power D., and Jerum G. Unrecognized anemia in patients with diabetes: a cross-sectional survey. Diabetes Care 26 (2003) 1164-1169
4. Bruno C.M., Sciacca T.C., Bertino G., Cilio D., Pellicano R., Marchese A.E., et al. Circulating erythropoietin in microalbuminuric type 2 diabetic patients with normal renal function: a pilot study. J Diabetes Complications 20 (2006) 376-379
5. Dikow R., Schwenger V., Schömig M., and Ritz E. How should we manage anaemia in patients with diabetes?. Nephrol Dial Transplant 17 (2001) 67-72
6. Bosman D.R., Winkler A.S., Marsden J.T., Macdougall I.C., and Watkins P.J. Anemia with erythropoietin deficiency occurs early in diabetic nephropathy. Diabetes Care 24 (2001) 495-499
7. Ishimura E., Nishizawa Y., Okuno S., Matsumoto N., Emoto M., Inaba M., et al. Diabetes mellitus increases the severity of anaemia in non-dialyzed patients with renal failure. J Nephrol 11 (1998) 83-86
8. Holland D.C., and Lam M. Predictors of hospitalization and death among pre-dialysis patients: a retrospective cohort study. Nephrol Dial Transplant 15 (2000) 650-658
9. Carmargo J.L., and Gross J.L. Conditions associated with very lowvalues of glycohaemoglobin measured by an HPLC method. J Clin Pathol 57 (2004) 346-349
10. Robert L.J., and Charles M.P. Hematologic alterations in diabetes mellitus. Am J Med 70 (1981) 339-352
11. Winkler A.S., Marsden J., Chaudhuri K.R., Hambley H., and Watkins P.J. Erythropoietin depletion and anaemia in diabetes mellitus. Diabet Med 16 (1999) 813-819
12. Koury M.J., and Bondurant M.D. Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. Science 248 (1990) 378-381
13. Radtke H.W., Claussner A., Erbes P.M., Scheuermann E.H., Schoepee W., and Koch K.M. Serum erythropoietin concentration in chronic renal failure: relationshikp to degree of anemia and excretory renal function. Blood 54 (1979) 877-884
14. Chandra M., Clemons G.K., and Mcvila M.I. Relation of serum erythropoietin levels to renal excretory function; evidence for lowered set point for erythropoietin production in chronic renal failure. J Pediatr 113 (1988) 1015-1021
15. Kallab A.S.M., Dabaghian G., and Terjanian T. Anemia secondary to low erythropoietin in a patient with normal renal function. Mt Sinai J Med 64 (1997) 406-408
16. National Kidney Foundation K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 39 2 Suppl. 1 (2002) S1-S266
17. National Kidney Foundation: NKF-DOQI clinical practice guidelines for the treatment of anaemia of chronic renal failure. New York: National Kidney Foundation; 2000 update. http://www.kdoqi.org.
18. Cotes P.M., and Brozovic B. Diurnal variation of serum immunoreactive erythropoietin in a normal subject. Clin Endocrinol (Oxf) 17 (1982) 419-422
19. Thomas M.C., Maclasaac R.J., Tsalamandris C., and Jerums G. Elevated iron indices in patients with diabetes. Diabet Med 21 (2004) 798-802
20. Valderrabano F., Hori W.H., MacDougall I.C., Rossert J., Rutowski B., and Wauters J.P. Pre-dialysis survey on anaemia management. Nephrol Dial Transplant 18 (2003) 89-100
21. Craig K.J., Williams J.D., Ri ley S.G., Smi th H., Owens D.R., Worthing D., et al. Anemia and diabetes in the absence of nephropathy. Diabetes Care 28 (2005) 1118-1123
22. Osterby R., Tapia J., Nyberg G., Tencer J., Willner J., Rippe B., et al. Renal structures in type 2 diabetic patients with elevated albumin excretion rate. APMIS 109 (2001) 751-761
23. Katz A., Caramori M.L., Sisson-Ross S., Groppoli T., Basgen J.M., and Mauer M. An increase in the cell component of the cortical interstitium antedates interstitial fibrosis in type 1 diabetic patients. Kidney Int 61 (2002) 2058-2066
24. Erturk S., Ates K., Durman N., Karatan O., Erbay B., and Ertug E. Unresponsiveness to recombinant human erythropoietin in haemodialysis patients: possible implications of angiotensin converting enzyme inhibitors. Nephrol Dial Transplant 11 (1996) 393-397
25. Hayashi K., Hasegawa K., and Kobayashi S. Effects of angiotensin-converting enzyme inhibitors on the treatment of anemia with erythropoietin. Kidney Int 60 (2001) 1910-1916
26. Cotroneo P., Maria R.B., Todaro L., Pitocco D., Manto A., Ruotolo V., et al. Blunted erythropoietin response to anaemia in patients with type1 diabetes. Diabetes Metab Res Rev 16 (2000) 172-176
27. Kim D.J., Kim Y.M., Yun Y.S., Ahn C.W., Cha B.S., Song Y.D., et al. Therapeutic effect of recombinant human erythropoietin on anaemia with erythropoietin deficiency in diabetic patients. Diabet Med 20 8 (2003) 661-664
28. Kojima K., and Totsuka Y. Anemia due to reduced serum erythropoietin concentration in non-uremic diabetic patients. Diabetes Res Clin Pract 27 3 (1995) 229-233
29. Yun Y.S., Lee H.C., Yoo N.C., Song Y.D., Lim S.K., Kim K.R., et al. Reduced erythropoietin responsiveness to anemia in diabetic patients before advanced diabetic nephropathy. Diabetes Res Clin Pract 46 3 (1999) 223-229
30. Kaysen G.A. The microinflammatory state in uremia: causes and potential consequences. J Am Soc Nephrol 12 (2001) 1549-1557
31. Goicoechea M., Martin J., de Sequera F., Quiroga J.A., Ortiz A., Carreno V., and Caramelo C. Role of cytokines in the response to erythropoietin in hemodialysis patients. Kidney Int 54 (1998) 1337-1343
32. Means Jr. R.T., and Kranz S.B. Progress in understanding the pathogenesis of the anaemia of chronic disease. Blood 80 (1992) 1639-1647
33. Bosman D.R., Osborne C.A., Marsden J.T., Macdougall I.C., Gardner W.N., and Watkins P.J. Erythropoietin response to hypoxia in patients with diabetic autonomic neuropathy and non-diabetic chronic renal failure. Diabet Med 19 (2002) 65-69
34. Hadjadj S., Torremocha F., Fanelli A., Brizard A., Bauwens M., and Marechaud R. Erythropoietin-dependent anaemia: a possible complication of diabetic neuropathy. Diab Metabol 27 3 (2001) 383-385
35. Donnely S., and Shah B.R. Erythropoietin deficiency in hyporeninemia. Am J Kidney Dis 33 (1999) 947-953
36. Bayes B., Serra A., Junca J., and Lanzurica R. Successful treatment of anaemia of nephritic syndrome with recombinant erythropoietin. Nephrol Dial Transplant 13 (1998) 1894-1895